Variation in Endpoints for FDA Approved Migraine Therapies
Dr. Jessica Ailani talks with Dr. Aaron Kesselheim and Leigh Sharpless about the endpoints used in trials supporting the US FDA approval of medications treating migraine.
Read the related article in Neurology.
his episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
Create your
podcast in
minutes
It is Free